PD-1/PD-L1 AXIS INHIBITORS AS PROMISING STRATEGY FOR MANAGEMENT OF HEPATOCELLULAR CARCINOMA: EXPECTATIONS, BOUNDARIES AND PITFALLS

High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

High expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy

Hepatocellular carcinoma care during The Coronavirus disease (COVID-19) era

Hepatocellular Carcinoma: Diagnosis and Therapeutic Options

Updates in Cancer Immunotherapy: Review Article

The Effect of Multidrug System on Treatment of Hepatocellular Carcinoma

Value of Regulatory T Cell in Hepatocellular Carcinoma Patients

Hepatocellular carcinoma before and after the era of direct-acting antiviral therapy for chronic hepatitis C: Dose the story differ?